Background and Objectives: A major limitation of dietary trials is that double blind design is not feasible. These trials are therefore prone to biases. The Lyon diet heart study is a single-blind secondary prevention trial to test the hypothesis that a Mediterranean-type of diet may prevent recurrences after a ®rst myocardial infarction. A surprising 73% reduction of the risk of new major cardiac events was observed in the experimental group. For this reason, it is important to describe the methods used in the trial. We now report our techniques to randomize the patients, to change their diet and to control for possible bias, in particular any investigator or attending physician bias. Design: In this dietary trial, a speci®c design was used to recruit and randomize the patients without informing them and their physicians that they were participating in a comparative trial. The attending physician bias was evaluated by studying drug usage and the investigator bias by constructing a questionnaire from which speci®c scores were used to evaluate (1) how the patients appreciated their participation in the study and (2) whether this participation resulted in signi®cant changes in their way of living. Subjects: 605 survivors of a ®rst myocardial infarction were randomized into either a control or a Mediterranean group. Results: The two randomized groups were similar for all the variables of prognosis. Drug usage was not signi®cantly different between groups, suggesting that there was no major attending physician bias. Analyses of the appreciation scores and of the change score did not detect any signi®cant investigator bias. Conclusions: Although the study cannot be completely shielded from minor biases, the data presented here provide evidence that the dietary modi®cations per se were protective, not other (including psychosocial) changes resulting from the participation to the trial. Descriptors: dietary trial; control of biases; coronary heart disease; Mediterranean diet; attending physician.
Introduction
Whereas dietary habits are thought to be involved in coronary heart disease, few controlled dietary trials have been conducted during the last decade, probably because of the many technical dif®culties inherent in such studies. One of the major dif®culties relates to the impossibility of carrying out double-blind trials. The investigators of the trials and/or the attending physicians of the patients in each group may thus introduce biases to the study. In addition, the complexity of dietary interventions based on a multifactorial approach limits the number of experimental patients. Also, a dietary intervention requires both speci®c communication techniques and multiple contacts between investigators and patients to obtain signi®cant and longlasting changes in the patients' dietary habits. Interpretation of the results requires monitoring of adhesion and longterm compliance to the tested diet in the experimental group. Finally, the duration of the trial should be relatively short to minimize possible inter-group contamination.
The Lyon diet heart study, of which an intermediate analysis has recently been published, is a secondary prevention trial in which a surprising and striking protective effect of a Mediterranean-type of diet was demonstrated in survivors of a ®rst myocardial infarction (de Lorgeril et al, 1994; Renaud et al, 1995) . In brief, a 73% reduction of the risk of cardiac death or non fatal infarct was observed in the experimental group (de Lorgeril et al, 1994) . When including major secondary events (episodes of unstable angina or severe heart failure, for instance) into the analyses, the risk reduction was also very high, reaching 76% (de Lorgeril et al, 1996) . Regarding the primary endpoint of the study (the combination of cardiac death and non fatal infarct) and contrary to what it was written in an Editorial (Mckeigue, 1994) , the 97% con®dence intervals ranged from 0.11± 0.65, suggesting that the minimal protective effect, in that population, reached a 35% risk reduction. Whereas a chance effect could not be ruled out totally, information regarding the general methodology and the means used by the investigators to check for possible biases may help to evaluate the plausibility of the results. In addition, although recent dietary trials in Great Britain and India (Singh et al, 1992) , based on similar approaches (dietary changes mimicking an ethnic cardioprotective diet but not aimed at reducing blood cholesterol), have shown results comparable to those of the Lyon study, the best way to con®rm the results should be to reproduce the study (namely testing the same type of Mediterranean diet) in a larger population and in a different context, for example in a country remote from the Mediterranean area. It is therefore of primary importance for future investigators (and Ethics Committees) to precisely know the methods used in the Lyon study. While the scienti®c background of the dietary intervention has been reported (Renaud and de Lorgeril, 1989) , the aims of this report were to describe the speci®c techniques used to randomize the patients, to change their diet and to check for possible bias.
Methods
The study design, participants and most of the methods have been previously described (de Lorgeril et al, 1994; Renaud et al, 1995) . Brie¯y, the Lyon diet heart study is a randomized, single-blind trial aimed at testing the hypothesis that a Mediterranean-type diet may reduce the risk of recurrent infarction and cardiovascular death in survivors of a ®rst acute myocardial infarction. A two-step recruitment technique, a variant of Zelen's design (Zelen, 1979) , was used. Patients who accepted to be followed up for ®ve years by the Research Unit (annual visit including clinical examination by a cardiologist, ECG recording and blood sampling for routine biological measurements) signed a ®rst consent form (without information regarding a dietary trial) and were randomized into a control or an experimental group. At this stage, patients of both groups were not fully informed about the study and only the patients randomized in the experimental group were invited to change their dietary habits and asked to sign a second consent form, in which they accepted to adopt a Mediterranean-type diet. However, neither the patients nor their attending physicians knew that they were participating in a comparative trial with an experimental and a control group. This design was used to avoid inter-group contamination, one of the major dif®culties of dietary trials, and also to avoid to in¯uence the attending physicians regarding how they would follow-up their patients and treat them in case of new symptom(s) or heart attack. In fact, it was suspected that, knowing group assignment, the physicians of both groups could, consciously or not, change their usual practice and consequently in¯uence the results of the trial (attending physician bias). Thus, control patients did not receive any dietary information from the investigators of the study. Also, dietary evaluation was not performed in control patients until the last year of follow-up, in order not to in¯uence them. This was ethically acceptable because most of these patients were expected to receive some dietary advice (similar, in principle, to the step 1 prudent diet of the American Heart Association) from the hospital dieticians, their cardiologist or their general practitioner. It is noteworthy that none of the patients randomized in the experimental group refused to sign the second consent form.
After the randomization visit, patients of both groups were scheduled to be seen two months later and then once a year at the Research Unit. These visits were added to, and did not replace, the visit to the attending physicians who were responsible for all aspects of treatment, including drug usage, invasive and non invasive diagnostic and therapeutic procedures.
Description of the dietary intervention
In practical terms, the dietary instructions were personalized and detailed to each patient. The techniques used to obtain these changes were patterned on those recommended in other settings by Erickson and Rossi (1975) and Watzlawick (1978) . Brie¯y, patients were advised to change their regular diet in two steps. The aim of the ®rst step was to prepare the patients to accept the detailed dietary instructions given in the second step, by anticipating and thus reducing their mental resistance to the changes. In this approach, the language of each patient (and family) was used when possible (Watzlawick, 1978) . Using general terms and simple words, the cardiologist of the study presented the Mediterranean civilization and explained what a Mediterranean diet means. He explained some cross-cultural epidemiological data and their relationships with ischemic heart disease. At this stage, the individual problem of the patient was not commented and no dietary recommendation was given yet.
The second step of the intervention was conducted by the dietician of the study and consisted in helping patients and their families to adapt their diet to the tested Mediterranean-type diet. This needed to take into account the wishes and gastronomic preferences of the patients, thus their geographic origin (South or North of France, Spain, Italy, North Africa, etc), the patient's occupation (does he/ she lunch at home), the number of people in the household, the ®nancial resources of the family, where the patient is living (center of city, small village), etc. Instructions had to be detailed, easy to comply with, safe, inexpensive and compatible with the way of living (namely single people, couple, large family, retired, unemployed, still working, etc), ethnic origin, gender and religion of each patient.
It must be noted that during follow-up and at subsequent re-instructions (once a year), investigators had to avoid con¯icts with the patients and their families. In particular, in case of major mistake of the patient, investigators had to admit that it was not the patient's fault (the patient being always right') but that investigators probably asked too much or demanded something that was`in a way unappropriate' as regards what the patient and his/her family were able to do.
Evaluation of the`physician bias'
Although the attending physicians were not directly informed by the investigators that their patients were included in a dietary trial, we examined the possibility that some of them understood that their patients were following an experimental cardioprotective diet. Actually, participation of a patient to a study might have in¯uenced the usual practice of his/her attending physician who remained responsible for the treatment, in particular drug treatment.
In order to detect any bias related to knowledge of group assignment by physicians, the drug treatment of each patient was scrutinized during follow-up. Chi-square tests (with an alpha risk of 0.01 according to the number of comparisons) were used at each year of follow-up to compare the proportions of patients in both groups who received cholesterol-lowering drugs, anticoagulants, aspirin, betablocking agents, calcium-channel blockers and angiotensin-converting enzyme (ACE) inhibitors.
Evaluation of the`investigator bias'
Because the study was not in double blind and in view of the lack of symmetry between the two groups in terms of Dietary trial to prevent coronary recurrences M de Lorgeril et al relations with the investigators, we evaluated whether experimental patients could have been advantaged (and their prognosis improved) through bene®cial effet(s) resulting from their participation in the study and not from the changes in their dietary habits. We thus examined whether investigators conducted the study similarly in the two groups irrespective of the diet intervention (investigator bias).
Because an`investigator bias' (potentially resulting in a kind of`placebo effect' more important in experimental patients than in controls) would essentially result from the subjective feelings of each patient, a self-administered questionnaire was constructed to assess how patients appreciated their participation in the study and how this participation induced changes in their daily life, including family life and ties, job, leisures, knowledge of the disease, etc. Speci®cally, two hypotheses were tested:
Hypothesis 1: experimental patients were advantaged over controls only because they changed their dietary habits (we tested a difference).
Smoking habits and alcohol intake (although objectively evaluated by other methods) were included in the same subjective analysis. Hypothesis 2: experimental patients were not advantaged over controls because of an additional (nonnutritional or non-orally related) bene®t in relation with the way they experienced their participation in the study or with the fact that they changed their way of living.
According to a methodology previously designed to examine the relationships between psychosocial attitudes and health (Mamelle et al, 1989) , this evaluation was conducted in three steps. Brie¯y, in a ®rst descriptive stage, we wanted to highlight how patients of both groups experienced their visits to the Research Unit and their meeting with the investigators (namely the cardiologist, nurse, laboratory technician, secretary, etc), other than the dietician who met only experimental patients. To achieve this, unstructured interviews were carried out in 21 patients by one psychologist (E C-V) independent of the principal investigators. From these interviews, some major items were extracted which, in a second step, allowed drawing up a self-administered questionnaire, the content of which is outlined in Table 1 . Once it has been determined whether the study was feasible and the questionnaire satisfactory (after some minor modi®cations), in a third step, consecutive patients of both groups coming to their 2nd, 3rd, 4th or 5th year annual visit were asked to complete the questionnaire. The questionnaires were anonymous to allow patients to feel totally free when completing it.
After detailed analysis of the answers to each question in the control group, questions were gathered to construct 4 speci®c scores allowing quantitation of the feelings of the patterns concerning the major selected items indicated in Table 1 . Brie¯y, the raw score (varying from 0 to 3 and 0 to 4) of each question was dichotomized in order to isolate positive appreciation regarding the participation to the study or signi®cant changes in the way of living. All the positive answers were then gathered to construct 3`appreciation scores' and 1`change score'. According to the method described by Blackwelder (1982) , to test hypothesis 1 (difference between groups regarding diet), it was calculated that with 30% of controls declaring to have changed their dietary habits, a signi®cant difference between groups would be detected (with an alpha risk of 0.05 and a beta risk of 0.05) if at least 60% of experimental patients admitted to have changed their diet, with a sample size of 100 patients per group.
To test hypothesis 2 (equivalence between groups), a sample size of 100 patients per group was also suf®cient to show that the difference between groups did not exceed 20% (with an alpha risk of 0.05 and a beta risk of 0.10), with a ®xed percentage of positive answers in each score of 50%.
Results
The main data of the Lyon diet heart study regarding patient accrual, baseline characteristics, follow-up and rate of withdrawal have been reported (de Lorgeril et al, 1994) . While recruitment was started in March 1988, an intermediate analysis was proposed by the Scienti®c Committee after a minimum follow-up of one year for each Table 1 General content of the self-administered questionnaire drawn up to evaluate how patients of both groups subjectively evaluated their participation in the study and whether they thought that this participation resulted in any change regarding either their way of living in general or, in particular, their dietary and smoking habits and their regular alcohol intake A total of 605 patients (303 controls and 302 experimental patients) have been randomized and included into the analysis. Patients were primarily male with a sex ratio around 90/10 in both groups. Mean age was 53.5 AE 10 s.d. y in both groups. Baseline characteristics were similar in both groups apart from smoking. The number of smokers at randomization was higher in the experimental group (7.6%) than in controls (4.9%; P`0.05) whereas after one year, the difference (19 vs 15%) was not signi®cant, as in subsequent years.
Drug usage and the`attending physician bias'
Concerning the use of anti-ischemic agents and ACE inhibitors, there was no difference between groups at randomization and during follow-up Table 2 ). The use of oral anticoagulants and aspirin being usually mutually exclusive in the same patient, it is noteworthy that the vast majority of patients of both groups were receiving antithrombotic medication. Between randomization and the one-year visit, there has been a signi®cant reduction in the use of beta-blocking agents in both groups.
Because the way of prescribing cholesterol-lowering drugs by physicians considerably changed over the years 1988±1993 in most countries and in France in particular, the results of Table 3 are given as a function of the postinfarction visit (A) and also as a function of the year (B). The use of statins is indicated independently. Whatever the way of analyzing, in function of either the visit or the year, results are concordant. Although the data show a tendency for a greater use of these drugs (in particular on the second year for all cholesterol-lowering drugs and in years 1992 and 1993 for statins) in control patients as compared with experimental patients, the differences between groups were not signi®cant.
All medications taken together, the data shown in Tables  2 and 3 indicate a parallel evolution in the two groups over the years, which suggests that participation of the patients in the trial apparently did not in¯uence the routine practice of the attending physicians in both groups.
Evaluation of the`investigator bias'
Two hundred and nineteen questionnaires (completed by 111 consecutive experimental and 108 consecutive control patients) were available for analysis. No patient refused to complete the questionnaire.
The percentages of patients of both groups who admitted to have changed their dietary habits, alcohol intake or smoking habits are indicated in Table 4 . As expected, 92% of the experimental patients declared to have modi®ed their diet, a result close to the evaluation performed by the dietician of the study using 24 h recall and frequency questionnaire (data not shown). Quite surprisingly, 42% of the control patients declared to have changed their dietary habits following their participation in the study. Also paradoxical is the fact that 36% of the experimental patients claimed to have reduced their alcohol intake (against 21% of controls, P 0.01) whereas investigators took care to be neutral as regards to alcohol intake. Finally, 38% of the experimental and 25% of the control patients (borderline signi®cant difference) claimed to have reduced their smoking habits following their participation in the study.
The percentages of patients in both groups who gave positive appreciation regarding their participation in the study and who admitted to have changed their way of living (apart from dietary and smoking habits and alcohol intake) are shown in Table 5 . The global appreciation regarding the participation in the study was positive in only 52% of the experimental and 57% of the control patients. Also, only 41% of the experimental and 42% of the control patients were positive (in other words, were totally satis®ed) concerning their possibility of communication with the investigators. On the other hand, 72% of the experimental and 80% of the control patients admitted to have changed something in their way of living (apart from diet, smoking and alcohol) secondary to their participation to the study. Thus for the four scores, the 95% con®dence intervals calculated in the experimental group were included in the intervals (20%) of the control group, which corresponds to the threshold calculated in the initial hypothesis to demonstrate an investigator bias (Blackwelder, 1982) .
Discussion
A known major limitation of dietary trials is that a double blind design is not feasible. These trials are therefore prone to various kinds of biases. Whereas the question of validation and classi®cation of the endpoints can be satisfactorily resolved by an Endpoint Committee working blindly and independently of the investigators, the issues of a possiblè investigator bias' and of the in¯uence of the attending physicians on the trials (`physician bias') raise particular dif®culties.
Attending physician bias
The in¯uence of the attending physicians on the trial and, conversely, the in¯uence of the trial on the current practice of physicians may actually be a source of bias. This was indirectly investigated by recording drug usage in both Dietary trial to prevent coronary recurrences M de Lorgeril et al groups throughout the study. It was indeed assumed that if doctors knowing the group assignment of their patient had consciously or unconsciously wished to interfere with the trial, this would have been primarily apparent in drug usage. This report shows that the two groups were similar for antithrombotic and antiischemic agents and for ACE inhibitors. Thus, participation in the trial did not signi®-cantly in¯uence physician practice in terms of cardiovascular medication. Because drug prescription is the easiest way to in¯uence prognosis in coronary heart disease, we can be relatively con®dent that for other more aggressive and complex medical attitudes, such as invasive or non invasive diagnostic (angiography) or therapeutic (angioplasty, coronary by-pass surgery) procedures, there was also no major difference between groups.
In fact, these data are not surprising since the attending physicians were not informed of group assignment by the investigators. In addition, most of the patients and their physicians did not clearly know that they were participating in a comparative trial. No dietary information was given to the control groups, whereas patients of both groups were receiving similar classical advice and answers regarding other aspects of lifestyle, including smoking, alcohol, exercise, stress, etc.
On the other hand, although the difference was not statistically signi®cant, there was a tendency to a greater use of cholesterol-lowering drugs, especially statins, in the control group as compared with the experimental patients. Mean blood cholesterol was, however, similar in both groups throughout the study (de Lorgeril et al, 1994) . This observation was apparently contradictory with the fact that the major determinant of elevated blood cholesterol, the intakes of saturated fat and cholesterol, was signi®cantly lower in experimental patients (de Lorgeril et al, 1994; Renaud et al, 1995) . This should have resulted in slightly lower blood cholesterol in experimental patients. A possible explanation could be that the cholesterol-lowering effect resulting from the reduced consumption of saturated fats in the experimental group was partly compensated by a concomitant reduced consumption of polyunsaturated fats. The latter could actually be as important as the saturated fats, at least in certain groups of patients, according to the current methods (for instance, the Keys equation, to cite only one) used to evaluate the cholesterol effect of dietary modi®cations. Another explanation is that the attending physicians spontaneously compensated for the difference in dietary cholesterol and saturated fat intakes by giving more cholesterol-lowering drugs to control patients, so that no difference between groups in the mean blood cholesterol was apparent on the annual visits at the Research Unit. The tendency toward a largest use of these drugs was apparent already at the ®rst year. The largest differences between groups were however on the fourth year, when 12.5% of controls were taking statins against 5.7% of experimental patients, and on the second year when 33.6% of controls were taking one kind of cholesterol-lowering drug against 23.8% of experimental patients. Thus, whereas the recent secondary prevention trial with Simvastatin showed a protective effect of simvastatin in certain low-risk coronary patients (4S, 1994) , it is unlikely, in the present study, that such a small difference in cholesterol-lowering drug usage might have signi®cantly in¯uenced the results. In any way, this slight difference would have advantaged the control group. As a matter of fact, in the Simvastatin Study, survival curves began to frankly diverge only after 2±3 y of follow-up, whereas in the present study a lowest recurrent rate was already present after 1 y in the experimental group, where the number of patients taking cholesterol-lowering drugs tended to be lowest.
Investigator bias
Another possible source of bias was that experimental patients could have been advantaged by additional bene®cial changes resulting from their participation in the trial, other than diet changes. Psychosocial factors, including social isolation and depression, have actually been documented as having an adverse impact on the prognosis of coronary patients, independently of the severity of the underlying cardiac disease (Frasure-Smith et al, 1993; Case et al, 1992; Williams et al, 1993) . It is thus conceivable that experimental patients and their families in this study may have perceived the disease as being more controllable as compared with controls because of the dietary management. The subjective perception of the disease has indeed been shown to in¯uence long-term prognosis at least in low-risk coronary disease patients (Baron et al, 1994) .
The results of this investigation is not in favour of this hypothesis in the Lyon study. Experimental patients do not feel to have been followed in a more bene®cial way than controls and the appreciation of the patients about their participation in the trial was similar in both groups. In fact, during a mean follow-up period of 27 months, the mean number of contacts between patients and investigators was about four in both groups. It is also noteworthy that the dietician of the study did not visit the experimental patients at home, as it was done in previous studies , thus multiplying the potentially bene®cial contacts between the patients and investigators. The number of contacts in the present study should be compared with the minimum of 11 contacts between patients and investigators in the Oslo diet heart study which excludes the many visits of the dieticians at the homes of the patients in the experimental group (Leren, 1966) . However, cardioprotection was borderline signi®cant after 5 y follow-up and non signi®cant after 11 y in the Oslo study (Leren, 1970) . In the DART study, over a period of two years, dieticians visited and telephoned regularly to the patients of the diet group while patients of both groups were seen by investigators only three times, at entry, after six months and two years of follow-up . In these conditions, a signi®cant 30% reduction in overall mortality was demonstrated . These various dietary studies suggest a minor role (if any) of investigators themselves in the cardioprotective effect (placebo effect) as compared with the diet intervention per se. In the Indian diet heart study, the two groups were followed similarly because both groups had to comply with a low-fat diet (Singh et al, 1992) . The tested diets differed only qualitatively and the numbers of contacts (every week for six weeks after discharge and then every 12 weeks) with investigators were similar in the two groups (Singh et al, 1992) . A 40% reduction of mortality was nevertheless demonstrated, which again suggests that in high-risk coronary patients, if any investigator bias can exist, it is probably negligible.
According to the feelings of the patients, in this study, there were not more changes in daily life on one group than in the other one, except for the changes in dietary habits and related lifestyle aspects such as alcohol intake and smoking. Whereas reduction of alcohol intake and smoking were not included among the Mediterranean diet recommendations, it is noteworthy that in the samples of patients who ®lled in the questionnaire (n 219), more experimental than control patients claimed to have reduced their alcohol intake and smoking. However, when considering the whole population, the number of smokers was signi®-cantly higher in the experimental group at randomization whereas there was no difference between groups after the ®rst year, nor over the following subsequent years. This suggests that more experimental patients actually stopped or did not re-start smoking during the trial. In fact, among patients encouraged to change their diet, such a`spillover' reduction in smoking and alcohol is not so surprising. As to alcohol intake, which was likely to be evaluated more objectively with the 24 h recall and frequency questionnaire than with a self-administered questionnaire, there was no signi®cant difference between groups (de Lorgeril et al, 1994) . This is in agreement with the traditional Mediterranean diet, which is not associated with abstinence. It is also possible that when answering the questionnaire, some experimental patients made an unconscious confusion between alcohol and smoking reduction on one hand and a prudent and reasonable way of living (which includes a safe diet) on the other hand, as is often presented in the general press and on TV. Finally, the data indicating that 92% of the patients randomized in the experimental group were actually following a Mediterranean diet suggest that once an adequate technique was employed to instruct high-risk patients, the Mediterranean diet was acceptable for most of them and their families and easy to follow in the long term. This is certainly one of the major lessons of this study. It does not mean, however, that it would have been the same in another country with patients having different traditions and ethnic origins. It is important to note that the city of Lyon is located only 100 km north of the Mediterranean area and that most of the patients recruited in the trial were native of the Lyon area or of some French or other (Italy, Spain and North Africa essentially) Mediterranean regions. Thus, they were expected to adhere relatively easily to the Mediterranean diet.
Conclusions
In summary, from the above data, it seems that systematic inquiry to detect biases related to the lack of a double-blind design in the Lyon trial was negative. Thus, although the study cannot be completely shielded from minor biases, it seems very likely that it is the dietary modi®cation per se which was responsible for the decrease in cardiac recurrences, and not other uncontrolled change(s) resulting from the participation in the trial.
